FREDRICK FOX: Open Payments
NPI 1760408702 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$784 in 39 payments from 11 companies in 2025. Trend: 2023 $1,099 · 2024 $1,239 · 2025 $784
Food & beverage: $784
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $263 |
| Otsuka America Pharmaceutical, Inc. | 6 | $97 |
| Corium, LLC | 3 | $66 |
| Vertical Pharmaceuticals, LLC | 3 | $60 |
| Tris Pharma Inc | 2 | $55 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Lundbeck LLC | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
Products named: CAPLYTA, REXULTI, Azstarys, Relexxii, FANAPT, INGREZZA, TRINTELLIX, UZEDY.
Industry payments across TX — which companies pay providers there.
